DOI . ORG {}

Analyzed Page
Matching Content Categories
CMS
Monthly Traffic Estimate
How Does Doi.org Make Money
Keywords
Topics
Questions
Schema
External Links
Analytics And Tracking
Libraries
Hosting Providers
CDN Services

We began analyzing https://link.springer.com/article/10.1007/s00251-004-0709-7, but it redirected us to https://link.springer.com/article/10.1007/s00251-004-0709-7. The analysis below is for the second page.

Title[redir]:
Enhancement to the RANKPEP resource for the prediction of peptide binding to MHC molecules using profiles | Immunogenetics
Description:
We introduced previously an on-line resource, RANKPEP that uses position specific scoring matrices (PSSMs) or profiles for the prediction of peptide-MHC class I (MHCI) binding as a basis for CD8 T-cell epitope identification. Here, using PSSMs that are structurally consistent with the binding mode of MHC class II (MHCII) ligands, we have extended RANKPEP to prediction of peptide-MHCII binding and anticipation of CD4 T-cell epitopes. Currently, 88 and 50 different MHCI and MHCII molecules, respectively, can be targeted for peptide binding predictions in RANKPEP. Because appropriate processing of antigenic peptides must occur prior to major histocompatibility complex (MHC) binding, cleavage site prediction methods are important adjuncts for T-cell epitope discovery. Given that the C-terminus of most MHCI-restricted epitopes results from proteasomal cleavage, we have modeled the cleavage site from known MHCI-restricted epitopes using statistical language models. The RANKPEP server now determines whether the C-terminus of any predicted MHCI ligand may result from such proteasomal cleavage. Also implemented is a variability masking function. This feature focuses prediction on conserved rather than highly variable protein segments encoded by infectious genomes, thereby offering identification of invariant T-cell epitopes to thwart mutation as an immune evasion mechanism.

Matching Content Categories {📚}

Education
Books & Literature
Science

Content Management System {📝}

What CMS is doi.org built with?

Custom-built

No common CMS systems were detected on Doi.org, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of doi.org audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Doi.org Make Money? {💸}

We can't figure out the monetization strategy.

Websites don't always need to be profitable; some serve as platforms for education or personal expression. Websites can serve multiple purposes. And this might be one of them. Doi.org might be earning cash quietly, but we haven't detected the monetization method.

Keywords {🔍}

google, scholar, pubmed, cas, article, mhc, class, binding, prediction, peptide, peptides, immunol, molecules, tcell, protein, biol, major, histocompatibility, motifs, epitopes, complex, acids, res, sequence, mol, reche, cleavage, nucleic, analysis, reinherz, bioinformatics, nature, processing, search, immunogenetics, rankpep, zhang, peptidemhc, epitope, language, structure, database, usa, rammensee, antigen, henikoff, privacy, cookies, content, research,

Topics {✒️}

vitro t-cell-mediated cytotoxicity month download article/chapter peptide binding predictions virtual matrix-based algorithms major histocompatibility complex position-specific gap penalties dana-farber cancer institute invariant t-cell epitopes candidate t-cell epitopes t-cell epitope discovery cd4 t-cell epitopes position-based sequence weights cd4 t-cell responses mhc class ii neural network-based prediction t-cell epitopes prediction allele-specific motifs revealed predict mhc-binding sequences structure-based algorithm t-cell receptor recognition structure-based prediction counter-propagation neural networks mhci-restricted epitopes results mhc superfamily structure variability masking function peptide-mhc class full article pdf flanking amino acids major proteolytic fragments covalently stabilized complex spoken language research peptide-mhc binding predicting peptide binding t-cell receptor privacy choices/manage cookies article immunogenetics aims mhc-binding peptides peptide-mhc complexes mhc-peptide complexes bell syst tech viral peptides presented mhc-binding motifs t-cell repertoire peptide-binding motifs peptide binding specificity mhci-restricted epitopes antigen peptide binding statistical language modeling hiv protein sequences t-cell recognition

Questions {❓}

Rosenfeld R (2000) Two decades of statistical language modeling: where do we go from here?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Enhancement to the RANKPEP resource for the prediction of peptide binding to MHC molecules using profiles
         description:We introduced previously an on-line resource, RANKPEP that uses position specific scoring matrices (PSSMs) or profiles for the prediction of peptide-MHC class I (MHCI) binding as a basis for CD8 T-cell epitope identification. Here, using PSSMs that are structurally consistent with the binding mode of MHC class II (MHCII) ligands, we have extended RANKPEP to prediction of peptide-MHCII binding and anticipation of CD4 T-cell epitopes. Currently, 88 and 50 different MHCI and MHCII molecules, respectively, can be targeted for peptide binding predictions in RANKPEP. Because appropriate processing of antigenic peptides must occur prior to major histocompatibility complex (MHC) binding, cleavage site prediction methods are important adjuncts for T-cell epitope discovery. Given that the C-terminus of most MHCI-restricted epitopes results from proteasomal cleavage, we have modeled the cleavage site from known MHCI-restricted epitopes using statistical language models. The RANKPEP server now determines whether the C-terminus of any predicted MHCI ligand may result from such proteasomal cleavage. Also implemented is a variability masking function. This feature focuses prediction on conserved rather than highly variable protein segments encoded by infectious genomes, thereby offering identification of invariant T-cell epitopes to thwart mutation as an immune evasion mechanism.
         datePublished:2004-09-03T00:00:00Z
         dateModified:2004-09-03T00:00:00Z
         pageStart:405
         pageEnd:419
         sameAs:https://doi.org/10.1007/s00251-004-0709-7
         keywords:
            Epitopes
            Major histocompatibility complex
            Prediction
            Profile
            Proteasome
            Immunology
            Human Genetics
            Gene Function
            Cell Biology
            Allergology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00251-004-0709-7/MediaObjects/s00251-004-0709-7fhc1.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00251-004-0709-7/MediaObjects/s00251-004-0709-7flb2.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00251-004-0709-7/MediaObjects/s00251-004-0709-7fhb3.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00251-004-0709-7/MediaObjects/s00251-004-0709-7fhb4.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00251-004-0709-7/MediaObjects/s00251-004-0709-7fhb5.jpg
         isPartOf:
            name:Immunogenetics
            issn:
               1432-1211
               0093-7711
            volumeNumber:56
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer-Verlag
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Pedro A. Reche
               affiliation:
                     name:Dana-Farber Cancer Institute
                     address:
                        name:Laboratory of Immunobiology and Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA
                        type:PostalAddress
                     type:Organization
                     name:Harvard Medical School
                     address:
                        name:Department of Medicine, Harvard Medical School, Boston, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:John-Paul Glutting
               affiliation:
                     name:Dana-Farber Cancer Institute
                     address:
                        name:Laboratory of Immunobiology and Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Hong Zhang
               affiliation:
                     name:Dana-Farber Cancer Institute
                     address:
                        name:Laboratory of Immunobiology and Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ellis L. Reinherz
               affiliation:
                     name:Dana-Farber Cancer Institute
                     address:
                        name:Laboratory of Immunobiology and Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA
                        type:PostalAddress
                     type:Organization
                     name:Harvard Medical School
                     address:
                        name:Department of Medicine, Harvard Medical School, Boston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Enhancement to the RANKPEP resource for the prediction of peptide binding to MHC molecules using profiles
      description:We introduced previously an on-line resource, RANKPEP that uses position specific scoring matrices (PSSMs) or profiles for the prediction of peptide-MHC class I (MHCI) binding as a basis for CD8 T-cell epitope identification. Here, using PSSMs that are structurally consistent with the binding mode of MHC class II (MHCII) ligands, we have extended RANKPEP to prediction of peptide-MHCII binding and anticipation of CD4 T-cell epitopes. Currently, 88 and 50 different MHCI and MHCII molecules, respectively, can be targeted for peptide binding predictions in RANKPEP. Because appropriate processing of antigenic peptides must occur prior to major histocompatibility complex (MHC) binding, cleavage site prediction methods are important adjuncts for T-cell epitope discovery. Given that the C-terminus of most MHCI-restricted epitopes results from proteasomal cleavage, we have modeled the cleavage site from known MHCI-restricted epitopes using statistical language models. The RANKPEP server now determines whether the C-terminus of any predicted MHCI ligand may result from such proteasomal cleavage. Also implemented is a variability masking function. This feature focuses prediction on conserved rather than highly variable protein segments encoded by infectious genomes, thereby offering identification of invariant T-cell epitopes to thwart mutation as an immune evasion mechanism.
      datePublished:2004-09-03T00:00:00Z
      dateModified:2004-09-03T00:00:00Z
      pageStart:405
      pageEnd:419
      sameAs:https://doi.org/10.1007/s00251-004-0709-7
      keywords:
         Epitopes
         Major histocompatibility complex
         Prediction
         Profile
         Proteasome
         Immunology
         Human Genetics
         Gene Function
         Cell Biology
         Allergology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00251-004-0709-7/MediaObjects/s00251-004-0709-7fhc1.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00251-004-0709-7/MediaObjects/s00251-004-0709-7flb2.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00251-004-0709-7/MediaObjects/s00251-004-0709-7fhb3.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00251-004-0709-7/MediaObjects/s00251-004-0709-7fhb4.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00251-004-0709-7/MediaObjects/s00251-004-0709-7fhb5.jpg
      isPartOf:
         name:Immunogenetics
         issn:
            1432-1211
            0093-7711
         volumeNumber:56
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer-Verlag
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Pedro A. Reche
            affiliation:
                  name:Dana-Farber Cancer Institute
                  address:
                     name:Laboratory of Immunobiology and Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA
                     type:PostalAddress
                  type:Organization
                  name:Harvard Medical School
                  address:
                     name:Department of Medicine, Harvard Medical School, Boston, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:John-Paul Glutting
            affiliation:
                  name:Dana-Farber Cancer Institute
                  address:
                     name:Laboratory of Immunobiology and Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Hong Zhang
            affiliation:
                  name:Dana-Farber Cancer Institute
                  address:
                     name:Laboratory of Immunobiology and Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ellis L. Reinherz
            affiliation:
                  name:Dana-Farber Cancer Institute
                  address:
                     name:Laboratory of Immunobiology and Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA
                     type:PostalAddress
                  type:Organization
                  name:Harvard Medical School
                  address:
                     name:Department of Medicine, Harvard Medical School, Boston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Immunogenetics
      issn:
         1432-1211
         0093-7711
      volumeNumber:56
Organization:
      name:Springer-Verlag
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Dana-Farber Cancer Institute
      address:
         name:Laboratory of Immunobiology and Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA
         type:PostalAddress
      name:Harvard Medical School
      address:
         name:Department of Medicine, Harvard Medical School, Boston, USA
         type:PostalAddress
      name:Dana-Farber Cancer Institute
      address:
         name:Laboratory of Immunobiology and Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA
         type:PostalAddress
      name:Dana-Farber Cancer Institute
      address:
         name:Laboratory of Immunobiology and Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA
         type:PostalAddress
      name:Dana-Farber Cancer Institute
      address:
         name:Laboratory of Immunobiology and Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA
         type:PostalAddress
      name:Harvard Medical School
      address:
         name:Department of Medicine, Harvard Medical School, Boston, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Pedro A. Reche
      affiliation:
            name:Dana-Farber Cancer Institute
            address:
               name:Laboratory of Immunobiology and Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA
               type:PostalAddress
            type:Organization
            name:Harvard Medical School
            address:
               name:Department of Medicine, Harvard Medical School, Boston, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:John-Paul Glutting
      affiliation:
            name:Dana-Farber Cancer Institute
            address:
               name:Laboratory of Immunobiology and Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA
               type:PostalAddress
            type:Organization
      name:Hong Zhang
      affiliation:
            name:Dana-Farber Cancer Institute
            address:
               name:Laboratory of Immunobiology and Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA
               type:PostalAddress
            type:Organization
      name:Ellis L. Reinherz
      affiliation:
            name:Dana-Farber Cancer Institute
            address:
               name:Laboratory of Immunobiology and Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA
               type:PostalAddress
            type:Organization
            name:Harvard Medical School
            address:
               name:Department of Medicine, Harvard Medical School, Boston, USA
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Laboratory of Immunobiology and Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA
      name:Department of Medicine, Harvard Medical School, Boston, USA
      name:Laboratory of Immunobiology and Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA
      name:Laboratory of Immunobiology and Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA
      name:Laboratory of Immunobiology and Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA
      name:Department of Medicine, Harvard Medical School, Boston, USA
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(306)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Foundation
Prism.js

Emails and Hosting {✉️}

Mail Servers:

mx.zoho.eu
mx2.zoho.eu
mx3.zoho.eu

Name Servers:

josh.ns.cloudflare.com
zita.ns.cloudflare.com

CDN Services {📦}

Crossref

4.72s.